Arvinas, Inc. (ARVN)
13.14
+0.04
(+0.31%)
USD |
NASDAQ |
Dec 10, 12:15
Arvinas Market Cap: 843.91M for Dec. 10, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Pfizer Inc. | 144.79B |
| Assembly Biosciences, Inc. | 569.42M |
| Alnylam Pharmaceuticals, Inc. | 53.94B |
| Verastem, Inc. | 765.25M |
| Sarepta Therapeutics, Inc. | 2.306B |
Market Cap Related Metrics
| PS Ratio | 3.061 |
| Price to Book Value | 1.495 |
| Price | 13.14 |
| Earnings Yield | -6.11% |